PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A309. A total of 62 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $8,000 | -27.3% | 6,000 | 0.0% | 0.00% | – |
| Q2 2021 | $11,000 | -99.9% | 6,000 | -99.8% | 0.00% | -100.0% |
| Q1 2021 | $13,807,000 | +708.8% | 3,095,741 | +558.3% | 0.31% | +675.0% |
| Q4 2020 | $1,707,000 | -6.2% | 470,255 | 0.0% | 0.04% | -13.0% |
| Q3 2020 | $1,820,000 | +5.2% | 470,255 | 0.0% | 0.05% | -4.2% |
| Q2 2020 | $1,730,000 | +81.2% | 470,255 | +15.7% | 0.05% | +23.1% |
| Q1 2020 | $955,000 | – | 406,355 | +406255.0% | 0.04% | – |
| Q4 2019 | $0 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 2,125,585 | $9,480,000 | 7.68% |
| DAFNA Capital Management LLC | 1,204,825 | $5,374,000 | 1.28% |
| Psagot Value Holdings Ltd. | 3,095,741 | $13,807,000 | 0.31% |
| Ground Swell Capital, LLC | 14,684 | $65,000 | 0.21% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 445,171 | $1,985,000,000 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 302,591 | $1,350,000 | 0.02% |
| Phoenix Holdings Ltd. | 244,113 | $1,089,000 | 0.02% |
| Virtu Financial LLC | 27,744 | $124,000 | 0.01% |
| D.A. DAVIDSON & CO. | 130,700 | $583,000 | 0.01% |
| Schonfeld Strategic Advisors LLC | 89,278 | $399,000 | 0.01% |